MétaCan
Menu
← Back to cohort
Record W2301960749 · doi:10.14288/1.0073817

Ultrastructural changes and mitochondrial DNA content in the hepatocytes of individuals co-infected with HIV and Hepatitis C virus following HCV combination therapy

2013· article· en· W2301960749 on OpenAlexaboutno aff
Hayley Hiebert

Bibliographic record

VenuecIRcle (University of British Columbia) · 2013
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsVirologyHepatitis C virusMitochondrial DNAHuman immunodeficiency virus (HIV)VirusHepacivirusUltrastructureFlaviviridaeBiologyMedicinePathologyGeneticsGene

Abstract

fetched live from OpenAlex

Background and objectives: Hepatitis C Virus (HCV) affects approximately 170 million people worldwide. Some estimates suggest up to 30% of these individuals are also infected with Human Immunodeficiency Virus (HIV). In Vancouver, British Columbia, the percent of HIV/HCV co-infected individuals is even greater, approaching 50% of those infected with HIV. Since the advent of highly active anti-retroviral therapy (HAART), the leading cause of death for HIV positive individuals is end stage liver disease often associated with chronic HCV infection. Previous work by our laboratory did not provide evidence of significant hepatocellular or mitochondrial toxicity associated with HAART treatment. Since it is suggested that drugs used in both HAART and HCV combination therapy may be toxic to the liver, the concurrent use of these treatments in co-infected individuals may be associated with increased hepatocellular and mitochondrial toxicity. The objective of this study was to determine the ultrastructural and mitochondrial DNA content changes that occur in liver hepatocytes in response to HCV combination therapy in co-infected individuals. Hypothesis: HCV combination therapy is associated with ultrastructural hepatocellular changes consistent with either damage or tissue repair in HIV and HCV co-infected patients. Methods: Liver biopsies were taken from co-infected patients before and after receiving HCV combination therapy. One biopsy was used for pathology assessment, the other was divided for nucleic acid assays and transmission electron microscopy (TEM). TEM samples were then examined for ultrastructural changes in hepatocytes following HCV combination therapy. Results: Biopsies from 11 subjects were collected. Of the subjects examined, liver pathology improved significantly following HCV combination therapy while no differences were observed in the mtDNA to nDNA ratio before and after treatment. Ultrastructural analysis of hepatocytes revealed a significant decrease in lipid content following HCV combination therapy. Conclusions: Overall, these results suggest that HCV combination therapy is beneficial to liver health and lessens liver pathology in HIV/HCV co-infected patients featuring a reduction in lipid content or steatosis. Future studies involving greater sample size are required to determine additional effects of HCV combination therapy on co-infected individuals.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.191
Teacher spread0.179 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes1
Has abstractyes

Explore more

Same venuecIRcle (University of British Columbia)→Same topicLiver Disease Diagnosis and Treatment→French-language works237,207→